Solvonis Therapeutics Plc SVNS
LSE · United Kingdom · Producer Manufacturing
GBp 0.1060-0.01 (-7.83%)
Market open· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) says new analysis of its ketamine-based alcohol treatment shows patients cut heavy drinking days by 67% compared with placebo, more than four months after their last dose. The company says that puts SVN-001 ahead of naltrexone, sold as Vivitrol,...
Diversified Energy Company PLC (LSE:DEC, NYSE:DEC, FRA:DG20) has agreed its biggest-ever deal, paying $1.8 billion for Permian Basin producer Birch. It should boost production by around 35%. Galliford Try Holdings PLC (LSE:GFRD, FRA:3WC) has landed a £110 million contract to improve water quality in the River Mease. It'll build a 23-kilometre pipeline for Severn Trent. Sunda Energy PLC (AIM:SNDA, FRA:GHA0) has seen a big upgrade at its Halcon prospect offshore the Philippines, now assigned 8 trillion cubic feet of gas resources. That gives Sunda a 3 Tcf net share. Rockfire Resources PLC (LSE:R
Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF), the London-listed biopharmaceutical company, has been granted a Notice of Allowance by the European Patent Office for a composition-of-matter patent covering its lead PTSD treatment. The allowance, which the company described as a "vital...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.